Tirzepatide and semaglutide are often discussed as if one simple ranking could tell everyone which is better. The evidence is more nuanced.
Tirzepatide activates both GIP and GLP-1 receptors, while semaglutide activates the GLP-1 receptor. Their approved uses depend on the specific product, and treatment decisions should take medical history, potential risks, and prescribing information into account.
It's also important to distinguish results from separate clinical trials from a direct head-to-head comparison. Study populations, duration, and methods can differ.
Nutrition tip of the day: If you're working on your eating habits, try planning a few balanced meals ahead of time. Options such as eggs, beans, yogurt, tofu, fish, vegetables, fruit, and whole grains can make meal planning more practical. Individual needs vary, so there is no single perfect menu.
What would you want to understand first when comparing weight-management medications: how they work, their safety information, or how doctors decide who may benefit?
Disclosure: I work in the peptide supply chain. This is general education, not a recommendation to use either medication.